In short
Clinical trials investigating Amoxicillin Sodium are studying how it performs in different patient groups and infections. These trials mainly look at safety, effectiveness, and treatment length in people with bone, joint, urinary, lung, skin, blood, or critical care infections. Some studies also compare Amoxicillin Sodium with other antibiotics or shorter treatment plans.
Key points
- Clinical trials involving Amoxicillin Sodium are being done in many infection settings, including bone and joint infections, urinary tract infection, erysipelas, pneumonia, bloodstream infection, and critical care. Most studies are Phase 3, with a few Phase 2 or low-intervention trials. The target groups include adults, children, pregnant women, critically ill patients, and people with specific surgical or hospital-related infections. Many trials compare Amoxicillin Sodium with other antibiotics or test shorter treatment durations. Main outcomes include clinical cure, remission, survival, treatment failure, and the need for extra antibiotics. Some studies also measure quality of life, costs, or antibiotic exposure in the blood.
Trial overview
The trial data show that Amoxicillin Sodium is being studied in several different clinical situations, mostly for infections. The studies are interventional, which means researchers assign treatments and compare results between groups. Most of the studies are in Phase 3, while a smaller number are in Phase 2 or low-intervention designs.
These trials do not focus on one single disease. Instead, they test Amoxicillin Sodium in bone and joint infections, urinary tract infection, skin infection, bloodstream infection, pneumonia, and severe infections in hospital or intensive care settings.
Patient groups and conditions
One important study includes patients with infection of osteosynthesis material, which means metal or other material used to hold a broken bone in place. These patients are treated after surgical cleaning of the infected area, with either the implant kept in place or removed.
Other trials include people with periprosthetic joint infection, which is an infection around an artificial joint such as a knee or hip replacement. Another study includes adults with lower-limb erysipelas, a skin infection, and another includes patients with febrile urinary tract infection, which means a urine infection with fever.
Some studies involve more serious hospital cases, such as uncomplicated enterococcal bacteremia, catheter-related bloodstream infection due to Staphylococcus aureus, severe COPD exacerbation, and serious infections in critically ill patients. There is also a study in children with systemic infections and another in pregnant women with premature rupture of membranes at term.
Trial designs and phases
Most Amoxicillin Sodium trials in the data are Phase 3 studies, which usually compare treatments in larger groups of patients. Examples include trials in osteosynthesis material infection, enterococcal bacteremia, erysipelas, community-acquired pneumonia, and catheter-related bloodstream infection.
There are also smaller or earlier studies. The urinary tract infection study is Phase 2, and the medication-related osteonecrosis of the jaw study is also Phase 2. Some studies are marked as low intervention, meaning the treatment strategy is being studied with less intense intervention than a standard drug trial.
The trials are usually randomized, open-label, or multicenter. Randomized means patients are assigned by chance to different treatment groups, and multicenter means the study is run in more than one hospital or clinic.
Main outcomes being measured
The studies measure different kinds of success depending on the infection being treated. In the osteosynthesis material trial, the main outcome is clinical failure, including return of symptoms, new signs of infection, need for extra antibiotics, and related surgical or culture findings.
In the urinary tract infection trial, the main outcome is clinical response, which includes no new healthcare visits or antibiotics, fever staying down, and symptoms improving at the test-of-cure visit. In the erysipelas trial, the main outcome is complete remission, meaning fever and local skin signs disappear and no extra antibiotics are needed.
Other studies use outcomes such as clinical success at test of cure, remission at a set week, vital status at day 28, cure without relapse at day 30, or the number of days alive without antibiotics. One trial in periprosthetic joint infection also focuses on cost-utility, which compares treatment costs with quality-adjusted life years, a measure that combines length and quality of life.
Special populations and care settings
Some Amoxicillin Sodium trials are built around special patient groups. These include critically ill children, elderly hospitalized patients with viral infection, adult haematology patients with chemotherapy-induced fever, and patients receiving CAR-T cell therapy for blood cancers.
Several studies also take place in intensive care units or other hospital settings where infection risk is high. In these settings, the studies may look at antibiotic exposure levels, days without antibiotics, or whether a shorter treatment plan is enough.
One trial in children studies early model-informed precision dosing, which means using early drug level information to help guide dosing so that treatment reaches the intended target. Another trial in critically ill patients measures whether antibiotic plasma targets are reached, which is a laboratory way to see if the drug level in blood matches the planned target.
What the trials compare
Many of the studies compare Amoxicillin Sodium with other antibiotics or with different treatment durations. For example, some trials compare a shorter course with a longer course, while others compare Amoxicillin Sodium-based treatment with another standard antibiotic plan.
In some trials, Amoxicillin Sodium is one option among several antibiotics listed in the protocol. In other trials, it appears as part of a broader treatment strategy being tested for infection control, recovery, or prevention of worsening disease.
Across the trial data, the main research goal is not to describe the drug itself, but to learn when Amoxicillin Sodium-based treatment works best, which patients may benefit, and whether shorter or alternative antibiotic strategies can give similar results.